(SNDA) Sonida Senior Living - Overview
Stock: Independent Living, Assisted Living, Memory Care, Home Care
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 59.9% |
| Relative Tail Risk | -14.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.00 |
| Alpha | 19.97 |
| Character TTM | |
|---|---|
| Beta | 1.095 |
| Beta Downside | 0.790 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.40% |
| CAGR/Max DD | 0.74 |
Description: SNDA Sonida Senior Living January 16, 2026
Sonida Senior Living, Inc. (NYSE: SNDA) operates a portfolio of senior-housing communities across the United States, delivering three core service tiers: independent living (amenities such as meals, transportation, and 24-hour staffing), assisted living (personal-care assistance, medication support, and supplemental services), and memory care (specialized dementia programming). The company also coordinates third-party home-care providers for physician, dental, podiatry, and rehabilitation services. Founded in 1990 and headquartered in Dallas, Texas, it rebranded from Capital Senior Living in November 2021.
Key performance indicators that investors typically track in this sector include occupancy rates (currently averaging ~86 % for Sonida’s communities, roughly in line with the national senior-housing median of 85 % as of Q3 2024), average daily rate (ADR) growth (Sonida reported a 4.2 % YoY increase to $2,340 per resident in the latest quarter), and same-store revenue growth (up 3.5 % YoY). The business is sensitive to macro drivers such as the aging of the U.S. baby-boomer cohort (projected to add ~10 million new seniors aged 65+ by 2030) and inflation-linked labor costs, which compress margins unless offset by pricing power or operational efficiencies.
Given the modest occupancy cushion and the sector’s exposure to regulatory changes, a deeper dive into Sonida’s cost-structure trends and pipeline of new openings is warranted; you might find additional context on ValueRay’s analytical platform helpful for that next step.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -46.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 1.38 > 1.0 |
| NWC/Revenue: -8.34% < 20% (prev 33.83%; Δ -42.17% < -1%) |
| CFO/TA 0.03 > 3% & CFO 21.6m > Net Income -46.5m |
| Net Debt (667.5m) to EBITDA (45.2m): 14.75 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.1m) vs 12m ago 17.13% < -2% |
| Gross Margin: 91.43% > 18% (prev 0.56%; Δ 9086 % > 0.5%) |
| Asset Turnover: 45.48% > 50% (prev 34.93%; Δ 10.55% > 0%) |
| Interest Coverage Ratio: -0.26 > 6 (EBITDA TTM 45.2m / Interest Expense TTM 38.2m) |
Altman Z'' -2.71
| A: -0.04 (Total Current Assets 72.5m - Total Current Liabilities 103.8m) / Total Assets 854.8m |
| B: -0.54 (Retained Earnings -461.2m / Total Assets 854.8m) |
| C: -0.01 (EBIT TTM -10.0m / Avg Total Assets 825.5m) |
| D: -0.60 (Book Value of Equity -461.0m / Total Liabilities 768.4m) |
| Altman-Z'' Score: -2.71 = D |
Beneish M -2.72
| DSRI: 1.15 (Receivables 19.7m/12.7m, Revenue 375.4m/278.1m) |
| GMI: 0.62 (GM 91.43% / 56.35%) |
| AQI: 1.61 (AQ_t 0.04 / AQ_t-1 0.03) |
| SGI: 1.35 (Revenue 375.4m / 278.1m) |
| TATA: -0.08 (NI -46.5m - CFO 21.6m) / TA 854.8m) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of SNDA shares?
Over the past week, the price has changed by +7.35%, over one month by +6.02%, over three months by +9.65% and over the past year by +40.41%.
Is SNDA a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNDA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.5 | -7.9% |
| Analysts Target Price | 31.5 | -7.9% |
| ValueRay Target Price | 34.4 | 0.6% |
SNDA Fundamental Data Overview February 03, 2026
P/B = 19.7266
Revenue TTM = 375.4m USD
EBIT TTM = -10.0m USD
EBITDA TTM = 45.2m USD
Long Term Debt = 663.4m USD (from longTermDebt, last quarter)
Short Term Debt = 21.0m USD (from shortTermDebt, last quarter)
Debt = 684.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 667.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.27b USD (597.8m + Debt 684.4m - CCE 17.0m)
Interest Coverage Ratio = -0.26 (Ebit TTM -10.0m / Interest Expense TTM 38.2m)
EV/FCF = -126.8x (Enterprise Value 1.27b / FCF TTM -9.98m)
FCF Yield = -0.79% (FCF TTM -9.98m / Enterprise Value 1.27b)
FCF Margin = -2.66% (FCF TTM -9.98m / Revenue TTM 375.4m)
Net Margin = -12.39% (Net Income TTM -46.5m / Revenue TTM 375.4m)
Gross Margin = 91.43% ((Revenue TTM 375.4m - Cost of Revenue TTM 32.2m) / Revenue TTM)
Gross Margin QoQ = 21.01% (prev 23.05%)
Tobins Q-Ratio = 1.48 (Enterprise Value 1.27b / Total Assets 854.8m)
Interest Expense / Debt = 1.45% (Interest Expense 9.91m / Debt 684.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -7.93m (EBIT -10.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.70 (Total Current Assets 72.5m / Total Current Liabilities 103.8m)
Debt / Equity = 8.45 (Debt 684.4m / totalStockholderEquity, last quarter 81.0m)
Debt / EBITDA = 14.75 (Net Debt 667.5m / EBITDA 45.2m)
Debt / FCF = -66.88 (negative FCF - burning cash) (Net Debt 667.5m / FCF TTM -9.98m)
Total Stockholder Equity = 105.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.63% (Net Income -46.5m / Total Assets 854.8m)
RoE = -44.08% (Net Income TTM -46.5m / Total Stockholder Equity 105.5m)
RoCE = -1.31% (EBIT -10.0m / Capital Employed (Equity 105.5m + L.T.Debt 663.4m))
RoIC = -1.10% (negative operating profit) (NOPAT -7.93m / Invested Capital 720.4m)
WACC = 5.25% (E(597.8m)/V(1.28b) * Re(9.95%) + D(684.4m)/V(1.28b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 57.14%
Fair Price DCF = unknown (Cash Flow -9.98m)
EPS Correlation: 38.59 | EPS CAGR: 121.3% | SUE: -0.43 | # QB: 0
Revenue Correlation: 94.72 | Revenue CAGR: 15.24% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-1.23 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-5.09 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=-34.0% | Growth Revenue=+4.8%